Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.
When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...
The JPMorgan Equity Premium ETF delivers an 8.11% yield through covered calls on large-cap stocks with monthly payouts of $4.59 annually. The SPDR Portfolio S&P 500 High Dividend ETF offers a 4.44% ...
Plume, a real world asset (RWA)-focused blockchain project, has debuted its Nest yield vaults directly on Solana, giving the network’s users native access to institutional-grade real-world assets for ...
The yield on the 10-year U.S. Treasury note is heading further back above 4%. The key borrowing benchmark briefly slipped below that threshold last week, reflecting growing confidence that the Federal ...
Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...
Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...
In Hans Christian Andersen's folktale, The Emperor's New Clothes, when a child cries out that the emperor is naked, he isn't revealing a secret. Everyone already knows it. What changes in that instant ...
Hosted on MSN
Where Will Recursion Pharmaceuticals Be in 5 Years?
Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...
A jump in weekly jobless claims and largely as-expected inflation data boosted bonds on Thursday, briefly driving the yield on the 10-year Treasury note below 4% for the first time since April.
Treasuries dropped, following a slump in longer-maturity European debt, with the US 30-year yield climbing toward 5% at the start of a month historically tough for long bonds. Longer-maturity yields ...
We recently published 12 Best Healthcare Stocks to Buy Under $30. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the best healthcare stocks. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results